Bicara Therapeutics Inc. (BCAX) Reports Q2 Loss of $0.82
Tweet
Share
E-mailGet Alerts BCAX Hot Sheet
Join SI Premium – FREE
Bicara Therapeutics Inc. (NASDAQ: BCAX) reported Q2 EPS of ($0.82).
For earnings history and earnings-related data on Bicara Therapeutics Inc. (BCAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
